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Diabetes mellitus is a chronic condition that 
arises when the pancreas does not produce 
enough insulin, or when the body cannot 
effectively use the insulin produced. Failure of 
insu lin secretion, insulin action or both leads to 
raised glucose levels in the blood and other 
metabolic changes which, if not controlled, can 
cause serious complications. The most 
important of these complications are 
nephropathy (affecting the kidneys), 
retinopathy (affecting the eyes), neuropathy 
(affecting the nerves) and cardiovascular 
disease (affecting the circulatory system) . 
Classification 
One problem over the years has been the 
classification of diabetes into different 
categories. Most recently, a World Health 
Organization (WHO) Consultation and the 
American Diabetes Association (ADA) Expert 
Committee have divided diabetes in to 4 main 
types . 
What was previously called insulin-dependent 
diabetes mellitus (IDDM) is now known as 
type I diabetes under this new classification, 
and non-insulin dependent diabetes mellitus 
(NIDDM) is now known as type 2 diabetes . 
Lesser degrees of abnormal glucose levels are 
also recognized.These include impaired 
glucose tolerance (IGT) and impaired 
fasting glycaemia {IFG). IGT describes 
blood glucose levels higher than normal but 
below the level of someone with diabetes. IFG 
describes raised fasting levels of glucose. IGT is 
now considered a risk category rather than a 
type of diabetes, and IFG represents a risk of 
25% to 50% of developing diabetes in the next 
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Table 1-1 
The four main types of diabetes 
I type I diabetes 
Insulin required for survival due to a lack 
of insulin produced by the body as a 
result of beta cell destruction 
2 type 2 diabetes 
Characterized by disorders of both 
insu lin action or secretion, either of 
which may predominate, both of which 
are usually present. Usually controlled by 
diet, exercise and oral hypoglycaemic 
agents. Insulin may be required for 
metabolic control 
3 Other specific types of diabetes 
Other types of diabetes where the cause 
is known (eg genetic defects in beta cell 
function or insulin action, diseases of the 
pancreas, certain other hormonal 
disorders or drug induced disorders) 
4 Gestational diabetes 
Diabetes appearing for the first time in 
pregnancy 
I 0 years. However, these are both particularly 
amenable to lifestyle interventions. 
The other major resu lt of the new classification 
is metabolic syndrome. This reflects the 
clustering of type 2 diabetes or IGT with 
several other major disease risk factors such as 
obesity, abnormal levels of lipids 
(dyslipidaemia), high blood pressure 
(hypertension), insulin resistance and a 
slightly increased excretion of protein in the 
urine (microalbuminuria) . 
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Risk Factors 
No clear-cut risk factors have been identified 
for type I diabetes. However, the risk factors 
for type 2 diabetes have been recognized. 
Risk Factors for type 2 diabetes 
• Age 
• Ethnicity 
• Family History 
• Obesity 
• Physical inactivity 
• Westernized diet 
The Extent of the Problem 
Diabetes is fast becoming a world epidemic. 
There are currently more than 177 million 
people with diabetes worldwide. WHO figures 
estimate that this will rise to 300 million by 
2025. Diabetes is the fourth main cause of 
death in most developed countries. Both type I 
There are currently 
more than 177 
million people with 
diabetes 
worldwide . WHO 
figures estimate that 
this will rise to 3 00 
million by 2025. 
and type 2 diabetes 
are spreading rapidly 
across the world . Type 
I diabetes accounts 
for less than I 0% of 
the total and is a 
particular problem in 
young Northern 
Europeans. It should 
be stressed that type 
I diabetes can occur 
at any age, and that 
there are as many people in the world with 
type I diabetes over the age of 20 years as 
there are under the age of 20.Type 2 diabetes, 
which accounts for about 90% of all cases of 
diabetes, is recording the most growth, 
Diabetes is the 
fourth main cause 
of death in most 
developed countries. 
particularly in rapidly 
developing countries. 
No part of the world 
is spared from 
diabetes. Table 1-2 
shows a selection of 
countries around the 
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Table 1-2 
Diabetes prevalence now and estimated for 2025 
Estimated Diabetes Prevalence (%) 
2003 2025 
United Arab Emirates 20.1 24.5 
Cuba 13.2 17.3 
China, Macau 8.2 12.9 
Ch ina, Hong Kong 8.8 12.8 
Germany 10.2 I 1.9 
Czech Republic 9.5 I 1.7 
Belarus, Republic of 6.9 10.7 
USA 8.0 9.3 
New Zealand 7.6 9.0 
Denmark 6.9 8.3 
Japan 6.9 7.9 
France 6.2 7.3 
Algeria 4.1 5.5 
Cameroon 0.8 1.2 
Source; Diabetes Atlas, Second edition, 
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world and their diabetes prevalence now and 
in 2025. 
In addition to these a.larming absolute rises in 
numbers, the re is also a worsening trend for 
the disease affecting younger age groups. In 
developed countries, the sharpest increase 
affect people over 65 years of age, whereas in 
the developing countries most new cases are 
occurring in those aged between 44 and 65 
years. In all parts of the wor ld type 2 diabetes 
is also now emerging in children and 
adolescents at an alarming rate, thereby raising 
the threat of the onset of complications at an 
earlier age . 
Future Outlook 
Although there is no evidence that type I 
diabetes is preventable, it is clear that there are 
ways to help prevent type 2 diabetes . If action 
is not taken now to stem the tide of type 2 
diabetes, the outlook for the health of the 
world is very bleak. The devastating 
complications of diabetes such as retinopathy, 
nephropathy and cardiovascular disease are 
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imposing a huge burden on national healthcare 
services . It is estimated that diabetes accounts 
for between S-1 0% of a nation's health budget. 
If action is not taken 
now to stem the tide 
oftype 2 diabetes, 
the outlook for the 
health of the world 
is very bleak. 
Studies in China, 
Tanzania, Finland and 
Sweden have proven 
that lifestyle changes 
can slow the 
development of 
diabetes in high-risk 
groups. Losing weight, 
eating healthily, and 
doing regular exercise have all shown to help 
prevent type 2 diabetes. The epidemic of type 2 
diabetes CAN be prevented but needs a high 
degree of dedication and commitment on a 
global S{;ale . Investing in prevention, particularly 
early detection, in order to avoid the onset of 
diabetic complications, can significantly reduce 
It is estimated that 
diabetes accounts 
for between 5-1 0% 
of a nation's health 
budget. 
the human and 
economic costs of 
diabetes. 
The message needs to 
be made loud and 
clear that type 2 
diabetes is a rapidly 
increasing disease but 
that li festyle change can help prevent it. Put 
simply: 'Eat Less , Walk More '. 
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